ALKERMES reported 223.39M in Gross Profit on Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Abbvie ABBV:US $ 9517M 1089M
Acadia Pharmaceuticals ACAD:US $ 112.52M 15.68M
Amgen AMGN:US $ 4677M 451M
Biogen BIIB:US $ 1777.9M 295.8M
Biomarin Pharmaceutical BMRN:US $ 402.39M 72.33M
Bristol Myers Squibb BMY:US $ 9177M 452M
Coherus Biosciences CHRS:US $ 50.74M 10.52M
Eli Lilly And LLY:US $ 5737.9M 211.8M
Gilead Sciences GILD:US $ 5166M 549M
H. Lundbeck A/S LUN:DC 3.53B 474M
Horizon Pharma HZNP:US $ 670.18M 102.77M
Intra Cellular Therapies ITCI:US $ 31.84M 8.71M
IONIS PHARMACEUT IONS:US $ 438M 307.99M
JAZZ PHA JAZZ:US $ 698.44M 62.14M
Johnson & Johnson JNJ:US $ 15828M 1021M
Marinus Pharmaceuticals MRNS:US 13.02M 11.5M
Merk MRK:US $ 10567M 873M
Nektar Therapeutics NKTR:US $ 18.85M 0.76M
Neurocrine Biosciences NBIX:US $ 306M 1.9M
Otsuka Holdings 4578:JP Y 254497M 10645M
Pfizer PFE:US $ 15651M 1516M
Regeneron Pharmaceuticals REGN:US $ 2560.2M 1408.9M
Revance Therapeutics RVNC:US $ 17.37M 701K
Teva Pharmaceutical Industries TEVA:US $ 1802M 323M
Vertex Pharmaceuticals VRTX:US $ 1851.7M 26.53M